74 related articles for article (PubMed ID: 16243295)
1. Differentiation-inducing factor-1 suppresses gene expression of cyclin D1 in tumor cells.
Yasmin T; Takahashi-Yanaga F; Mori J; Miwa Y; Hirata M; Watanabe Y; Morimoto S; Sasaguri T
Biochem Biophys Res Commun; 2005 Dec; 338(2):903-9. PubMed ID: 16243295
[TBL] [Abstract][Full Text] [Related]
2. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
[TBL] [Abstract][Full Text] [Related]
3. DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines.
Jingushi K; Takahashi-Yanaga F; Yoshihara T; Shiraishi F; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
Biochem Pharmacol; 2012 Jan; 83(1):47-56. PubMed ID: 22005519
[TBL] [Abstract][Full Text] [Related]
4. Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma.
Mori J; Takahashi-Yanaga F; Miwa Y; Watanabe Y; Hirata M; Morimoto S; Shirasuna K; Sasaguri T
Exp Cell Res; 2005 Nov; 310(2):426-33. PubMed ID: 16153639
[TBL] [Abstract][Full Text] [Related]
5. DIF-1 inhibits tumor growth in vivo reducing phosphorylation of GSK-3β and expressions of cyclin D1 and TCF7L2 in cancer model mice.
Takahashi-Yanaga F; Yoshihara T; Jingushi K; Igawa K; Tomooka K; Watanabe Y; Morimoto S; Nakatsu Y; Tsuzuki T; Nakabeppu Y; Sasaguri T
Biochem Pharmacol; 2014 Jun; 89(3):340-8. PubMed ID: 24670930
[TBL] [Abstract][Full Text] [Related]
6. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
7. Differentiation-inducing factor-3 inhibits intestinal tumor growth in vitro and in vivo.
Kubokura N; Takahashi-Yanaga F; Arioka M; Yoshihara T; Igawa K; Tomooka K; Morimoto S; Nakatsu Y; Tsuzuki T; Nakabeppu Y; Matsumoto T; Kitazono T; Sasaguri T
J Pharmacol Sci; 2015 Apr; 127(4):446-55. PubMed ID: 25913757
[TBL] [Abstract][Full Text] [Related]
8. Coordinated expression of cyclin D1 and LEF-1/TCF transcription factor is restricted to a subset of hepatocellular carcinoma.
Schmitt-Graeff A; Ertelt-Heitzmann V; Allgaier HP; Olschewski M; Nitschke R; Haxelmans S; Koelble K; Behrens J; Blum HE
Liver Int; 2005 Aug; 25(4):839-47. PubMed ID: 15998435
[TBL] [Abstract][Full Text] [Related]
9. Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3beta and degrades cyclin D1 in mammalian cells.
Takahashi-Yanaga F; Taba Y; Miwa Y; Kubohara Y; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
J Biol Chem; 2003 Mar; 278(11):9663-70. PubMed ID: 12522140
[TBL] [Abstract][Full Text] [Related]
10. Regulation of smooth muscle cell proliferation by beta-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression.
Quasnichka H; Slater SC; Beeching CA; Boehm M; Sala-Newby GB; George SJ
Circ Res; 2006 Dec; 99(12):1329-37. PubMed ID: 17122440
[TBL] [Abstract][Full Text] [Related]
11. Involvement of GSK-3beta and DYRK1B in differentiation-inducing factor-3-induced phosphorylation of cyclin D1 in HeLa cells.
Takahashi-Yanaga F; Mori J; Matsuzaki E; Watanabe Y; Hirata M; Miwa Y; Morimoto S; Sasaguri T
J Biol Chem; 2006 Dec; 281(50):38489-97. PubMed ID: 17046823
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells.
Sakoguchi-Okada N; Takahashi-Yanaga F; Fukada K; Shiraishi F; Taba Y; Miwa Y; Morimoto S; Iida M; Sasaguri T
Biochem Pharmacol; 2007 May; 73(9):1318-29. PubMed ID: 17270149
[TBL] [Abstract][Full Text] [Related]
13. Lovastatin protects human neurons against Abeta-induced toxicity and causes activation of beta-catenin-TCF/LEF signaling.
Salins P; Shawesh S; He Y; Dibrov A; Kashour T; Arthur G; Amara F
Neurosci Lett; 2007 Feb; 412(3):211-6. PubMed ID: 17234346
[TBL] [Abstract][Full Text] [Related]
14. Retinol decreases beta-catenin protein levels in retinoic acid-resistant colon cancer cell lines.
Dillard AC; Lane MA
Mol Carcinog; 2007 Apr; 46(4):315-29. PubMed ID: 17219422
[TBL] [Abstract][Full Text] [Related]
15. Differentiation-inducing factor-1 enhances 5-fluorouracil action on oral cancer cells inhibiting E2F1 and thymidylate synthase mRNAs accumulation.
Sprio AE; Di Scipio F; Ceppi P; Salamone P; Di Carlo F; Scagliotti GV; Papotti M; Ceccarelli A; Berta GN
Cancer Chemother Pharmacol; 2012 Apr; 69(4):983-9. PubMed ID: 22139443
[TBL] [Abstract][Full Text] [Related]
16. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone suppresses DU145 cell proliferation and cell cycle through inhibition of the extracellular signal-regulated kinase 1/2 pathway and cyclin D1 expression.
Gao QZ; Lu JJ; Liu ZD; Zhang H; Wang SM; Xu H
Asian J Androl; 2008 Jul; 10(4):635-41. PubMed ID: 18097517
[TBL] [Abstract][Full Text] [Related]
18. Differentiation-inducing factor-1 suppresses the expression of c-Myc in the human cancer cell lines.
Jingushi K; Nakamura T; Takahashi-Yanaga F; Matsuzaki E; Watanabe Y; Yoshihara T; Morimoto S; Sasaguri T
J Pharmacol Sci; 2013; 121(2):103-9. PubMed ID: 23357875
[TBL] [Abstract][Full Text] [Related]
19. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
20. Progesterone initiates Wnt-beta-catenin signaling but estradiol is required for nuclear activation and synchronous proliferation of rat uterine stromal cells.
Rider V; Isuzugawa K; Twarog M; Jones S; Cameron B; Imakawa K; Fang J
J Endocrinol; 2006 Dec; 191(3):537-48. PubMed ID: 17170212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
